Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...

from NDTV News - Topstories https://ift.tt/35BsWI9
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Planning To Buy New iPhone? It Sells Cheapest In These Countries

The iPhone 18 Pro and iPhone 18 Pro Max are the company's latest premium smartphones, while the iPhone Duo marks Apple's entry into ...